Usporedba oslikavanja prostate magnetskom rezonancijom 1.5T i 3T

Autor(i)

  • Goran Kutlić University Hospital “Holy Spirit”, Zagreb, Croatia , University Department of Health Studies, University of Split, Split, Croatia Autor
  • Krešimir Dolić University Department of Health Studies, University of Split, Split, Croatia , Department of Diagnostic and Interventional Radiology, University Hospital of Split,Split, Croatia , School of Medicine, University of Split, Split, Croatia Autor

DOI:

https://doi.org/10.55378/rv.49.1.5

Ključne riječi:

MRI, prostata, 1.5T, 3T

Sažetak

Izvrsnim prikazom mekih tkiva i mogućnostima trodimenzionalnog prikaza magnetska rezonancija od svojih je početaka prije 40 godina do danas postala jedna od temeljnih dijagnostika u prikazu prostate i njezinih patoloških stanja. Iako je veća dostupnost uređaja za magnetsku rezonanciju snage polja 1.5T, preporuka Europskog udruženja urogenitalnih radiologa je da se snimanje prostate magnetskom rezonancijom vrši na uređajima snage polja 3T. Uređaji snage 3T nametnuli su se zbog povećanog omjera signala i šuma (SNR) koji se može iskoristi za skraćenje vremena snimanja ili povećanja rezolucije, tj. poboljšanja kvalitete slike. Sve je više istraživanja primjene kvantitativnih tehnika, kao što su engl. Magnetic resonance fingerprinting, T2 mapiranje, BOLD, kojima bi se mogla poboljšati detekcija i kvantificiranje lezija kracinoma prostate, a optimizacijom protokola na 1.5T i 3T moguće je učiniti pretrage jednake dijagnostičke vrijednosti.

Reference

PI-RADS v2.1. (preuzeto 12.2.2023.) Dostupno na https://www.acr.org/-/media/ACR/Files/RADS/Pi-RADS/PIRADS-v2-1.pdf

Giganti F., Rosenkrantz B. A., Villeirs G., Panebianco V., Stabile A., Emberton M., Moore C. M. The Evolution of MRI of the Prostate: The Past, the Present, and the Future. AJR Am J Roentgenol. 2019 Aug; 213(2): 384-396.

Giganti F, Allen C. Imaging quality and prostate MR: it is time to improve. Br J Radiol. 2021 Feb 1;94(1118):20200934. doi: 10.1259/bjr.20200934.

Westbrook C., Talbot J. MRI in Practice, 5th Edition. Wiley-Blackwell, 2018.

Jambor I. Optimization of prostate MRI acquisition and post-processing protocol: a pictorial review with access to acquisition protocols. Acta Radiol Open. 2017 Dec 8;6(12):2058460117745574. doi: 10.1177/2058460117745574.

Maier SE, Wallström J, Langkilde F, Johansson J, Kuczera S, Hugosson J, Hellström M. Prostate Cancer Diffusion-Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion-Weighting Level Matter? J Magn Reson Imaging. 2022 Mar;55(3):842-853. doi: 10.1002/jmri.27895.

Tamada T, Kido A, Ueda Y, Takeuchi M, Fukunaga T, Sone T, Yamamoto A. Clinical impact of ultra-high b-value (3000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3T: comparison with b-value of 2000 s/mm2. Br J Radiol. 2022 Mar 1;95(1131):20210465. doi: 10.1259/bjr.20210465.

Polanec SH, Lazar M, Wengert GJ, Bickel H, Spick C, Susani M, Shariat S, Clauser P, Baltzer PAT. 3D T2-weighted imaging to shorten multiparametric prostate MRI protocols. Eur Radiol. 2018 Apr;28(4):1634-1641. doi: 10.1007/s00330-017-5120-5.

Vidya Shankar R, Roccia E, Cruz G, Neji R, Botnar R, Prezzi D, Goh V, Prieto C, Dregely I. Accelerated 3D T2 w-imaging of the prostate with 1-millimeter isotropic resolution in less than 3 minutes. Magn Reson Med. 2019 Aug;82(2):721-731. doi: 10.1002/mrm.27764.

Caglic I, Povalej Brzan P, Warren AY, Bratt O, Shah N, Barrett T. Defining the incremental value of 3D T2-weighted imaging in the assessment of prostate cancer extracapsular extension. Eur Radiol. 2019 Oct;29(10):5488-5497. doi: 10.1007/s00330-019-06070-6.

Alonzi R, Taylor NJ, Stirling JJ, d’Arcy JA, Collins DJ, Saunders MI, Hoskin PJ, Padhani AR. Reproducibility and correlation between quantitative and semiquantitative dynamic and intrinsic susceptibility-weighted MRI parameters in the benign and malignant human prostate. J Magn Reson Imaging. 2010 Jul;32(1):155-64. doi: 10.1002/jmri.22215.

Kim Y, Park JJ, Kim CK. Blood oxygenation level-dependent MRI at 3T for differentiating prostate cancer from benign tissue: a preliminary experience. Br J Radiol 2022; 95: 20210461.

Klingebiel M, Schimmöller L, Weiland E, Franiel T, Jannusch K, Kirchner J, Hilbert T, Strecker R, Arsov C, Wittsack HJ, Albers P, Antoch G, Ullrich T. Value of T2 Mapping MRI for Prostate Cancer Detection and Classification. J Magn Reson Imaging. 2022 Aug;56(2):413-422. doi: 10.1002/jmri.28061.

Mai J, Abubrig M, Lehmann T, Hilbert T, Weiland E, Grimm MO, Teichgräber U, Franiel T. T2 Mapping in Prostate Cancer. Invest Radiol. 2019 Mar;54(3):146-152. doi: 10.1097/RLI.0000000000000520.

Sathiadoss P, Schieda N, Haroon M, Osman H, Alrasheed S, Flood TA, Melkus G. Utility of Quantitative T2-Mapping Compared to Conventional and Advanced Diffusion Weighted Imaging Techniques for Multiparametric Prostate MRI in Men with Hip Prosthesis. J Magn Reson Imaging. 2022 Jan;55(1):265-274. doi: 10.1002/jmri.27803.

Al-Bourini O, Seif Amir Hosseini A, Giganti F, Balz J, Heitz LG, Voit D, Lotz J, Trojan L, Frahm J, Uhlig A, Uhlig J. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment. Invest Radiol. 2022 Dec 8. doi: 10.1097/RLI.0000000000000945.

Sushentsev N, Kaggie JD, Slough RA, Carmo B, Barrett T. Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study. PLoS One. 2021 Jan 29;16(1):e0245970. doi: 10.1371/journal.pone. 0245970.

Shiradkar R, Panda A, Leo P, Janowczyk A, Farre X, Janaki N, Li L, Pahwa S, Mahran A, Buzzy C, Fu P, Elliott R, MacLennan G, Ponsky L, Gulani V, Madabhushi A. T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology. Eur Radiol. 2021 Mar;31(3):1336-1346. doi: 10.1007/s00330-020-07214-9..

Tamada T, Kido A, Yamamoto A, Takeuchi M, Miyaji Y, Moriya T, Sone T. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1. J Magn Reson Imaging. 2021 Jan;53(1):283-291. doi: 10.1002/jmri.27283.

Felisi M, Monti AF, Lizio D, Nici S, Pellegrini RG, Riga S, Bortolato B, Brambilla MG, Carbonini C, Abujami M, Carsana C, Sibio D, Potente C, Vanzulli A, Palazzi MF, Torresin A. MRI only in a patient with prostate cancer with bilateral metal hip prostheses: case study. Tumori. 2021 Dec;107(6):NP41-NP44. doi: 10.1177/0300891621997549.

Ullrich T, Quentin M, Oelers C, Dietzel F, Sawicki LM, Arsov C, Rabenalt R, Albers P, Antoch G, Blondin D, Wittsack HJ, Schimmöller L. Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: A prospective comparison study of image quality. Eur J Radiol. 2017 May;90:192-197.

Virarkar M, Szklaruk J, Diab R, Bassett R, Bhosale P. Diagnostic value of 3.0 T versus 1.5 T MRI in staging prostate cancer: systematic review and meta-analysis. Pol J Radiol. 2022 Jul 29;87:e421-e429.

Kutlić G. Usporedba oslikavanja prostate magnetskom rezonancijom 1.5 T i 3 T (Diplomski rad). Split: Sveučilište u Splitu, Sveučilišni odjel zdravstvenih studija; 2023 (pristupljeno13.01.2025.) Dostupno na: https://urn.nsk.hr/urn:nbn:hr:176:919786

COVER Comparison of magnetic resonance imaging of the prostate 1.5T and 3T

Preuzimanja

Objavljeno

11.04.2025

Kako citirati

Kutlić, Goran, i Krešimir Dolić. 2025. „Usporedba Oslikavanja Prostate Magnetskom Rezonancijom 1.5T I 3T“. Radiološki Vjesnik 49 (1): 38-47. https://doi.org/10.55378/rv.49.1.5.

Slični članci

11-19 od 19

Također možete Započni napredno pretraživanje sličnosti za ovaj članak.

Najčitaniji članci istog autora / istih autora